According to the Zhitong Finance App, McPharmaceutical-B (02335) announced results for the six months ended June 30, 2026. The group obtained additional revenue of RMB 1,335 million during the period, an increase of 9.25% over the previous year; losses attributable to the company's owners amounted to RMB 231 million, an increase of 372.08% over the previous year; and the basic loss per share was 0.88 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.